Navigation Links
Avantium and BP Extend Strategic Partnership
Date:10/16/2007

AMSTERDAM, October 16 /PRNewswire/ -- Avantium, a leading technology company servicing the oil, chemicals and pharmaceutical industries, announces the three-year extension of the strategic research collaboration with BP, one of the world's largest energy companies.

Avantium provides innovative, high value-added R&D services and tools to the energy, chemicals and pharmaceutical industries, and has a long standing relationship with BP. The collaboration builds on the strategic relationship between BP and Avantium that was initiated in 2005. The strategic research collaboration in the area of purified terephthalic acid (PTA) is extended for a period of 3 years. During this period Avantium will apply its advanced high-throughput R&D technology, services and modeling capabilities in the research and technology portfolio of BP's PTA business.

Tom van Aken, Chief Executive Officer of Avantium: "We are very pleased to continue our strategic relationship with BP. Over the past years, the teams of BP and Avantium have successfully collaborated to apply our unique technological capabilities to BP's PTA business. The continuation of our joint efforts is an excellent proof of the added value of our technology and expertise."

Sue Davison, Business Technology Manager BP Aromatics and Acetyls: "This strategic collaboration with Avantium is consistent with BP's global technology position in PTA, and affirms our commitment to continue to employ leading technologies such as high-throughput R&D for continual improvement of our PTA business."

Profile Avantium

Avantium is a leading technology company in the area of advanced high-throughput R&D operating in the energy, chemicals and pharmaceutical industries. The company develops products and processes in the area of biofuels, bio-based chemicals and novel crystal forms of existing drugs by applying its proprietary, high-throughput R&D technology. Avantium has demonstrated the potential of this technology by providing R&D services and tools to more than 70 companies worldwide, including many of the world's largest energy, chemicals and pharmaceutical companies. Avantium has approximately 100 employees; its offices and head quarters are based in Amsterdam.

Other information

This release may contain certain forward-looking statements relating to the business, financial performance and results of Avantium and the industry in which it operates. These statements are based on its current plans, estimates and projections, as well as its expectations of external conditions and events. A number of important factors, and the inherent risks and uncertainties that such statements involve, could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements.

In the event of any inconsistency between an English version and a Dutch version of this document, the English version will prevail over the Dutch version.

For further information:

Website: http://www.avantium.com


'/>"/>
SOURCE Avantium Technologies B.V.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Medicare Drug Deadline not to be extended
2. Liver key to extending life
3. Regular exercise linked to extended menstrual cycles
4. Even mid-life diet change can extend life
5. Extended Therapy for Blood Clots
6. Friendship can extend lifespan
7. Genes to Extend Longevity Discovered
8. India extends National TB Control Program
9. Breast Cancer Funding To Be Extended By Another $30 Million: Pharmac
10. Drug Courts In Europe Extended For Three More Years
11. Single Dose Of Extended Release Metformin Found To Be Effective In Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... Washington, DC (PRWEB) , ... July 26, 2017 ... ... Arise Infusion is pleased to now offer a major advancement in drug therapy ... their lives. Ocrevus (pronounced Ah-creh-vus) is a novel B cell targeted therapy ...
(Date:7/26/2017)... Yorba Linda, Ca (PRWEB) , ... July 26, 2017 , ... ... of optimize lyophilization processes. Inconsistent results freeze drying samples and a lengthy freeze dry ... , This webinar will discuss freeze drying techniques, as well as new accessories and ...
(Date:7/26/2017)... ... July 26, 2017 , ... ... host its 2017 Process Validation and Process Validation Statistics Conferences in Bethesda, ... process validation lifecycle challenges faced by process validation professionals and statisticians today. ...
(Date:7/26/2017)... ... ... Team Type 1 Foundation, a nonprofit organization pursuing a global mission of education, ... announce the 106 college athletes with type 1 diabetes who will receive scholarships as ... 1 Foundation has bestowed a total of 271 college scholarships to athletes with type ...
(Date:7/26/2017)... ... July 26, 2017 , ... IDC-Eating Disorder Care ... the treatment program located in Royal Oak, Michigan. IDC, formerly known as ... focused on providing the highest standards in the field of eating disorder treatment in ...
Breaking Medicine News(10 mins):
(Date:7/14/2017)... , July 13, 2017 It should come ... States is in the midst of a crippling ... , since 1999, the number of overdose deaths from opiate-based ... in over half a million dead from 2001 to 2015". ... oxycodone, and hydrocodone has similarly quadrupled, drawing a compelling link ...
(Date:7/12/2017)... , July 12, 2017  Eli Lilly and Company (NYSE: ... with generic companies to resolve pending patent litigation in the ... Virginia regarding the Cialis ® (tadalafil) unit ... April 26, 2020. As part of the agreement, Cialis exclusivity ... 27, 2018. "The unit dose patent for Cialis ...
(Date:7/11/2017)... SARASOTA, Fla. , July 11, 2017  Dr. Echenberg, founder of ... Dilator therapy program to patients who suffer from painful intercourse and other ... vaginismus and vaginal atrophy due to menopause. ... VuVatech LLC ... Dilators , created by Sarasota, Florida -based start-up company, ...
Breaking Medicine Technology: